Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Metlen Energy & Metals

M&A Activity • Jun 26, 2025

2755_rns_2025-06-26_6db0e713-ea96-4e36-974b-1643fb2689e7.pdf

M&A Activity

Open in Viewer

Opens in native device viewer

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD VIOLATE THE LAWS OF THAT JURISDICTION

METLEN ENERGY & METALS PLC

ANNOUNCEMENT

METLEN ENERGY & METALS PLC ( Metlen PLC or the Offeror ) has received all requisite regulatory approvals for the commencement of the Acceptance Period of the Tender Offer

The Acceptance Period will commence on 27.06.2025 and will end on 25.07.2025

Trading of the Metlen PLC shares on and is expected to commence on 04.08.2025

26.06.2025

Law on 25.06.2025 Tender Offer Date Metlen PLC, a public limited company incorporated under the laws of England & Wales, Tender Offer all ordinary registered shares, (each, a Company Share ) issued by Metlen Energy & Metals S.A. Metlen S.A. which Metlen PLC does not hold directly or indirectly, in consideration for new Euro denominated ordinary shares of Metlen PLC (each a Consideration Share one-for-one.

1. Regulatory Approvals

  • 1.1 Metlen PLC announces that, following:
  • (a) the approval by the FCA of the prospectus submitted in connection with the admission to listing of all Euro denominated ordinary registered shares (the Offeror Shares on the equity shares ESCC Category Official List to trading on the LSE Main Market UK Prospectus 26.06.2025;
  • (b) HCMC the prospectus relating to the public offering of the Consideration Shares in Greece pursuant to the Tender Offer and the listing and admission to trading of all Offeror Shares on the Athens Exchange (the Prospectus 26.06.2025; and
  • (c) the approval by the HCMC of the information circular that Metlen PLC has prepared in Information Circular 26.06.2025,

Metlen PLC has received all requisite regulatory approvals for the commencement of the Acceptance Period (as defined below).

  • 1.2 National Bank of Greece S.A. and Piraeus Bank S.A., act as advisors to Metlen PLC (i) in respect Advisor Advisors and (ii) as listing advisors to Metlen PLC in relation to the secondary listing of all Offeror Shares on the ATHEX .
  • 1.3 A summary of the expected timetable of principal events for the Tender Offer follows:

Date Event

  • 26.06.2025 Approval of the Information Circular by the CMC Announcement for the approval and publication of the Information Circular - Publication of the Information Circular
  • 27.06.2025 Commencement of the Acceptance Period
  • 25.07.2025 End of the Acceptance Period and final date for satisfaction of the Admission Condition and Acceptance Prerequisite (as defined below)
  • 29.07.2025 Announcement of the results of the Tender Offer
  • 01.08.2025 Completion and settlement of the Tender Offer and issue of the Consideration Shares - Crediting of Offeror Shares to CREST and DSS accounts
  • 04.08.2025 Admission and commencement of trading of the Offeror Shares on the LSE and ATHEX

2. Acceptance Period

  • 2.1 The period of time during which the holders of Company Shareholders may accept the Tender Offer Declaration of Acceptance to their participant or intermediary which is a qualified member of the Greek DSS Participant/Intermediary and DSS respectively) and through which they hold their Company Shares starts on 27.06.2025, at 08.00 am (Greek time) and ends on 25.07.2025 Acceptance Period
  • 2.2 Alternatively, for their own facilitation, Shareholders who wish to accept the Tender Offer may authorise at their own initiative their DSS Participant/Intermediary to fill-in, sign, submit or dispatch the Declaration of Acceptance and in general to proceed with all requested actions with a view to accepting the Tender Offer on their behalf. Forms of Declarations of Acceptance shall be provided through the DSS Participants/Intermediaries throughout the Acceptance Period.

3. The Tender Offer

  • 3.1 Pursuant to article 2, paragraph (e) of the Law, persons acting in concert with the Offeror and among themselves for the purposes of the Tender Offer are (i) Mr. Evangelos Mytilineos, founder and sole shareholder of the Offeror (the Major Shareholder , and (ii) Emergia Holdings Ltd, Frezia Ltd, Kilteo Ltd, Melvet Investments Ltd and Rocaldo Ltd, which are controlled, in the sense of article 3, paragraph 1(c) of Law 3556/2007, by the Major Shareholder (the Concerted Persons ). Apart from the aforementioned persons, there are no other persons acting in concert with the Offeror for the purposes of the Tender Offer, pursuant to article 2, case (e) of the Law.
  • 3.2 While at the date on which Metlen PLC initiated the Tender Offer process by informing the Date of the Tender Offer holds no Company Shares, it is deemed under the Law to hold indirectly the voting rights deriving from the 30,899,783 Company Shares, which are directly held by each of the Major Shareholder and each of Frezia Ltd, Kilteo Ltd and Melvet Investments Ltd, corresponding to approximately 21.59% of the total share capital and voting rights in Metlen Concerted Persons Shares Other than the Concerted Persons Shares, the Concerted Persons do not hold any Company Shares or voting rights in the Company.
  • 3.3 Metlen PLC has received written statements from the Major Shareholder and each of Frezia Ltd, Kilteo Ltd, Melvet Investments Ltd, and Fairfax, to tender in the Tender Offer 40,087,830 Company Shares, which represent in total approximately 28.01% of the voting rights in Metlen S.A., in exchange for Consideration Shares, in accordance with the terms and subject to the conditions of the Tender Offer.
  • 3.4 Other than the aforementioned written statements received by the Offeror from the Major Shareholder and each of Frezia Ltd, Kilteo Ltd, Melvet Investments Ltd and Fairfax, there are no special agreements relating to the Tender Offer or the exercise of rights arising from the Company Shares to which the Offeror or another Concerted Person is a party.

4. Consideration

  • 4.1 Metlen PLC offers, in consideration for every Company Share lawfully and validly tendered during the Acceptance Period, one (1) new Consideration Share. Shareholders who tender their Company Shares in the Tender Offer will have the option to receive, for each Company Share lawfully and validly tendered in the Tender Offer, one Consideration Share in dematerialised form through either CREST, a computerised system of the United Kingdom for the paperless settlement of sales and purchases of securities and the holding of uncertificated securities, or the DSS.
  • 4.2 The Consideration Shares carry the right to dividends, capital returns, distributions from distributable reserves or other distributions that may be made by Metlen PLC after the date settlement of the Tender Offer has completed. Detailed information in relation to, among other matters, the Consideration Shares and the rights of the holders of Consideration Shares is included in the Prospectus and the Information Circular.
  • 4.3 Metlen PLC will assume payment of the clearing duties levied in favor of the Hellenic Central Securities Depositary S.A. ATHEXCSD on the registration of the transfer of the Company Shares tendered to Metlen PLC, in accordance with the Codified Resolution 18 (Meeting 311/22.02.2021) of the Board of Directors of the ATHEXCSD, which would otherwise be payable by the Shareholders Accepting Shareholders . Such duties amount to 0.08% and are calculated in accordance with the provisions of such decision.
  • 4.4 According to the circular issued by the Greek Independent Authority for Public Revenue with in exchange for Consideration Shares will not be subject to the tax provided for by article 9 paragraph 2 of Law 2579/1998 in favour of the Greek State, which currently amounts to 0.10% and is imposed on sales of shares listed on the ATHEX, since such transfer will not qualify as a sale under such law. As a result, Accepting Shareholders who elect to receive Consideration Shares through either CREST or the DSS will not be required to pay such tax, while Accepting Shareholders who elect to receive the Cash Alternative (as defined below) in the context of the exercise of the right of squeeze-out or the right to sell-out, as defined in articles 27 and 28 of the Law respectively, will be required to pay such tax.

5. Information Circular - Prospectus

5.1 Beginning on 27.06.2025 and for the whole duration of the Acceptance Period, printed copies of the Information Circular will be available, free of charge, at any of the branches of the Advisors in Greece, and in electronic form through the websites of the Offeror (https://www.metlengroup.com/share-exchange), the Advisors (National Bank of Greece: https://www.nbg.gr/el/footer/enimerwtika-deltia and Piraeus Bank https://www.piraeusholdings.gr) and of the ATHEX (https://www.athexgroup.gr/el). The Information Circular will also be posted on the website of the HCMC (www.hcmc.gr/el_GR/web/portal/deltiaprotaseon12minou).

Shareholders who wish to obtain additional information regarding the procedure for submitting Declarations of Acceptance may contact their DSS Participant/Intermediary through whom their tendered Company Shares are held in the DSS, during business days and hours.

  • 5.2 The Prospectus is in English and includes a Greek translation of the Summary. The Prospectus will be available to the public in electronic form, in accordance with article 21, par. 2, of Regulation (EU) 2017/1129 (the Prospectus Regulation , on the following websites:
    • Athens Exchange: https://www.athexgroup.gr/el/raise-capital/list/how-to/new-listedissuers
    • Group website: https://www.metlengroup.com/share-exchange
    • National Bank of Greece: https://www.nbg.gr/el/footer/enimerwtika-deltia
    • Piraeus Bank: https://piraeusholdings.gr/metlen

In accordance with article 21 paragraph 5 of the Prospectus Regulation, the HCMC publishes on its website (http://www.hcmc.gr/el_GR/web/portal/elib/deltia) all approved prospectuses.

6. Results of the Tender Offer

It is expected that the results of the Tender Offer will be announced on 29.07.2025 and the delivery of the Consideration Shares to the Accepting Shareholders will be completed on or about 01.08.2025, subject to paragraph 7 below.

7. Condition and Prerequisite

  • 7.1 Completion of the Tender Offer is subject to the following condition and prerequisite:
  • (a) the FCA and the LSE shall have acknowledged to Metlen PLC or its agent (and such acknowledgment shall not have been withdrawn) on or prior to the end of the Acceptance Period that the application for admission of the Offeror Shares to the ESCC Category of the Official List and to trading on the LSE's main market for listed securities has been or will be approved, provided that such approval will become effective upon (i) the submission by Metlen PLC or its agent (in practice, the financial institution(s) acting as sponsor(s) for the admission) to the FCA of a shareholder statement in customary form, evidencing satisfaction of the requirement under UK Listing Rule 5.5.1 that a minimum percentage of the Offeror Shares will be in "public hands" upon such admission (the "minimum free float requirement"), and confirmation of the number and par value of the Offeror Shares to be issued pursuant to the Tender Offer; (ii) the issuance of the Offeror Shares pursuant to the Tender Offer; and (iii) the issuance of a dealing notice by the FCA; and (b) based on the level of valid acceptances received by the end of the Acceptance Period the minimum free float requirement (10 per cent.) will be met as at Admission (the "Admission Condition"), and
  • (b) no later than the end of the Acceptance Period, at least 128,797,345 Company Shares corresponding to at least 90% of the total share capital and voting rights of Metlen S.A., including, for this purpose, the Concerted Persons Shares, shall have been lawfully and validly tendered and not withdrawn as at the end of the Acceptance Period (the "Acceptance Prerequisite").
  • 7.2 In case the Admission Condition and/or the Acceptance Prerequisite is not satisfied by the end of the Acceptance Period, the Tender Offer will automatically lapse, namely that it will have no legal effect, and the Company Shares tendered will be returned to their holders.
  • 7.3 The Offer may revoke the Tender Offer if (i) a competing offer, as provided by the Law, has

circumstances beyond the control of the Offeror occurs that makes the Tender Offer particularly onerous.

7.4 The declarations of acceptance which are submitted cannot be revoked, unless (i) a competing offer, as provided by the Law, has been submitted, or (ii) following the publication of any supplement to the Prospectus by the Offeror, in which case the accepting shareholder will be entitled to exercise a revocation right.

8. Right of Squeeze-out / Right to Sell-out

  • 8.1 If at the end of the Acceptance Period, Metlen PLC holds at least 128,797,345 Company Shares representing at least 90% of the total voting rights in Metlen S.A., including for this purpose the Concerted Persons Shares:
  • (a) Metlen PLC will initiate the squeeze-out procedure under the Law to cause any remaining Shareholders to transfer those Company Shares to Metlen PLC, in accordance with the Law Right of Squeeze-Out
  • (b) Shareholders who have not accepted the Tender Offer will be entitled, within a period of three (3) months from the publication of the results of the Tender Offer, to exercise the right to sell-Right to Sell-Out
  • 8.2 The consideration offered for each Company Share regarding both the Right of Squeeze-Out and the Right to Sell-Out, is, at the election of the holder, either one Consideration Share in dematerialised form held through either CREST or the DSS 39.62 Cash Alternative -weighted average market price of Company Shares on the ATHEX (adjusted for the valid tick size of the price for the Company Share) over the six months ended on 24.06.2025, the last trading day preceding the Date of the Tender Offer.
  • 8.3 The Cash Alternative meets the criteria of the fair and reasonable consideration according to article 9 of the Law, since:
    • (a) the volume weighted average stock market price for the Company Share, as applicable, during the six (6) months preceding the Date of the Tender Offer amounts to 39.606 Euro, according to the data of the ATHEX; and
    • (b) neither the Offeror nor the Concerted Persons acquired Company Shares during the twelve months preceding the Date of the Tender Offer at a price per Company Share above the Cash Alternative.

A valuation of the Company Shares is not required under paragraph 6 of article 9 of the Law, as none of the conditions mentioned therein apply, namely:

  • (i) the conditions of paragraph 6, case (a) are not met, since no sanctions have been imposed by the Board of Directors of the HCMC for market manipulation of the Company Shares within the eighteen (18) months prior to the Date of the Tender Offer,
  • (ii) the conditions of paragraph 6, case (b) are not met, since the Company Shares have been traded for more than three-fifths (3/5) of the operating days of the ATHEX, i.e., 120 out of 120 operating days, and the transactions carried out exceed ten percent (10%) of the total Company Shares, during the six (6) months prior to the Date of the Tender Offer, i.e., in particular amounted to about 24% of the total of the Company Shares;
  • (iii) the conditions of paragraph 6, case (e), are not met, since the fair and reasonable consideration, as determined by the criteria of paragraph 4 of article 9 of the Law, is greater than eighty percent (80%) of the book value per Company Share, based on the average figures from the last two published financial statements of the Company

20.30 per Company Share 16.24).

9. Delisting of the Metlen S.A. Shares from the ATHEX

9.1 If following completion of the Tender Offer or the exercise of the Right of Squeeze-out or the Right to Sell-out, as applicable, Metlen PLC holds Company Shares representing at least 95% on of a General Meeting of the shareholders of Metlen S.A. to approve the submission of an application to the HCMC requesting the delisting of the Company Shares from the ATHEX, in accordance with article 17, paragraph 5 of Law 3371/2005, at which (general meeting) Metlen PLC will exercise its voting rights in favour of such resolution.

Important Notices

General

  • The Tender Offer described herein is addressed to holders of Metlen S.A. Shares and only to persons to whom it may be lawfully addressed. The Tender Offer will be made in the territory of the Hellenic Republic. The making of the Tender Offer to specific persons who are residents in or nationals or citizens of jurisdictions outside the Hellenic Republic or to custodians, Excluded Shareholders accordance with the laws of the relevant jurisdiction. It is the responsibility of the Excluded Shareholders and each person wishing to accept the Tender Offer to inform themselves of and ensure compliance with the laws of their respective jurisdictions in relation to the Tender Offer. If you have any doubts as to your status, you should consult with your professional advisor in the relevant jurisdiction.
  • The Tender Offer is not being made, directly or indirectly, by mail or by any means in or into the United States of America, Australia, Canada, Japan or any other jurisdiction within which, under its laws, rules and regulations, the submission, the making or the presentation of the Tender Offer or the mailing or distribution of the Information Circular to be approved by the HCMC a declaration of acceptance and any other document or material relevant thereto Relevant Documents ion, rule Excluded Territories Documents and materials will not be, and must not be, directly or indirectly, mailed, distributed or otherwise sent to anyone or from anyone in or into or from any Excluded Territory.
  • No Offeror Shares have been offered or will be offered pursuant to the Tender Offer to the public in the United Kingdom prior to the publication of a prospectus in relation to the Offeror Shares which has been approved by the Financial Conduct Authority, except that the Offeror Shares may be offered to the public in the United Kingdom at any time: (a) to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation; (b) to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the Advisors for any such offer; or (c) in any other circumstances falling within Section 86 of the FSMA. provided that no such offer of the Offeror Shares shall require Metlen PLC or any Advisor to publish a prospectus pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. For the purposes of this provision, the communication in any form and by any means of sufficient information on the terms of the offer and any Offeror Shares to be offered so as to enable an investor to decide to purchase Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

In addition, in the United Kingdom, the materials are being distributed only to, and are directed only at, "qualified investors" within the meaning of Article 2(e) of the UK version of the UK Prospectus Regulation who are also (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); (b) high net worth entities falling within Article 49(2)(a) to (d) of the Order; and (c) other persons to whom they may otherwise lawfully be communicated (all such persons referred to in (a), (b) and (c) together being referred to as "Relevant Persons"). Any investment or investment activity to which the materials relate is available only to Relevant Persons in the United Kingdom and will only be engaged with such persons.

  • The Consideration Shares have not been and will not be registered under the U.S. Securities Securities Act registration or an exemption from the registration requirements of the Securities Act. Metlen PLC has no intention to register any part of the Tender Offer in the United States or make a public offering of the Consideration Shares in the United States. Any Consideration Shares offered in the United States will be offered only to (i) holders of the Company Shares located outside of the United States and (ii) holders of Company Shares located within the United States that are Qualified Institutional Buyers (as defined in Rule 144A under the U.S. Securities Act of 1933).
  • The Offeror Shares are issued to the Company's existing shareholders in Singapore without the intention of being on-sold there, and no documents issued by or on behalf of the Company may be used in any subsequent sale by these shareholders. The Information Circular has not been and will not be lodged with or registered as a prospectus under the Securities and Futures Act 2001 of Singapore with the Monetary Authority of Singapore. Therefore, the Information Circular does not constitute an offer or invitation for the sale or purchase of the Offeror Shares in Singapore, whether directly or indirectly, and shall not form the basis of any contract for the issue or sale of the Consideration Shares in Singapore.
  • This announcement is only made available to a limited number of "Professional Investors" Financial Activities Rule Book, as amended. By receiving this announcement, the entity to whom it has been issued understands, acknowledges and agrees that it has not been approved by or filed with the UAE Central Bank, the UAE Securities and Commodities Authority, the Dubai Financial Services Authority ("DFSA"), the Financial Services Regulatory Authority of Abu Dhabi ("FSRA") or any other relevant regulatory or licensing authorities in the UAE, nor has the originator, or any other related party received authorization or licensing from the UAE Central Bank, the UAE Securities and Commodities Authority, the DFSA, the FSRA, or any other authorities in the UAE. This announcement does not constitute a public offer of Offeror Shares in the UAE in accordance with the UAE SCA Chairman of the Board Resolution No. (11/R.M) of 2016 On the Regulations for Issuing and Offering Shares of Public Joint Stock Companies, Federal Decree-No. 32 of 2021 on Commercial Companies, or otherwise.
  • The Offeror Shares may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act ("FinSA") and no application has or will be made to admit the Offeror Shares to trading on any trading venue (exchange or multilateral trading facility) in Switzerland. The Information Circular and any related offering or marketing materials regarding the Offeror Shares do not constitute a prospectus under the FinSA and must not be publicly distributed or made available in Switzerland.
  • The Offeror Shares have not been licensed for offering in Kuwait by the Kuwait Capital Markets Authority or any other relevant Kuwaiti government agency. The offering of the Offeror Shares in Kuwait on the basis a private placement or public offering is, therefore, restricted in accordance with Law No. 7 of 2010 and the bylaws thereto (as amended). No private or public

offering of the Offeror Shares is being made in Kuwait, and no agreement relating to the sale of the Ordinary Shares will be concluded in Kuwait. No marketing or solicitation or inducement activities are being used to offer or market the Offeror Shares in Kuwait.

  • The Offeror Shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the Offeror Shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.
  • The Offeror Shares have not been and will not be registered in Japan pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended, the "FIEA") in reliance upon the exemption from the registration requirements since the offering constitutes the private placement to qualified institutional investors only as provided for in "i" of Article 2, Paragraph 3, Item 2 of the FIEA. A transferor of the Offeror Shares shall not transfer or resell them except where a transferee is a qualified institutional investor under Article 10 of the Cabinet Office Ordinance concerning Definitions provided in Article 2 of the Financial Instruments and Exchange Act of Japan (the Ministry of Finance Ordinance No. 14 of 1993, as amended).
  • This announcement does not constitute an invitation to the public in the Cayman Islands. Any invitation to participate in the Tender Offer is not being conducted in or from with the Cayman Islands or a place of business in the Cayman Islands.
  • No person receiving a copy of this announcement or of any Relevant Document in any jurisdiction outside the Hellenic Republic may treat any such document as if it constituted a solicitation or offer to such person and under no circumstances may such person use any Relevant Document if, in the relevant jurisdiction, such solicitation or offer may not be lawfully made to such person or if such Relevant Document may not be lawfully used without breaching any legal requirements. In those instances, any such Relevant Document is sent for information purposes only.
  • This regulatory announcement does not contain, constitute or form part of any offer or invitation to sell or subscribe or any solicitation of any offer to purchase or subscribe for any securities in any jurisdiction, and neither this regulatory announcement (nor any part of it) nor the fact of its distribution form the basis of, or may be relied upon in connection with, or act as any inducement to enter into, any contract or commitment whatsoever.

Cautionary Statement Regarding Forward-Looking Statements

The information contained in this announcement does not purport to be full or complete. The exact dates of the Tender Offer and the Admission may change. The Tender Offer and the Admission will relation to the Tender Offer and the Admission.

This announcement contains forward-looking statements that involve risks and uncertainties relating to, amongst others, the business activities and certain plans and objectives that Metlen PLC has in respect of the Group. There are many factors (including, without limitation, commercial, operational, economic, political and financial), as a consequence of which the actual results and the actual developments may potentially substantially differ from the plans and the objectives of Metlen PLC and the Group set out in the announcement.

Although Metlen PLC believes that, as of the date of this announcement, the expectations reflected in the forward-looking statements are reasonable, Metlen PLC cannot assure you that future events will

meet these expectations. Moreover, neither Metlen PLC nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. After the date of this announcement, unless Metlen PLC is required by applicable law to update these forward-looking statements, Metlen PLC will not necessarily update any of these forward-looking statements to conform them either to actual results or to changes in expectations.

_____________________________

More from Metlen Energy & Metals

Capital/Financing Update 2026
Jan 5
Regulatory Filings 2026
Jan 5
Director's Dealing 2025
Nov 20
Capital/Financing Update 2025
Nov 19
Director's Dealing 2025
Nov 19
Director's Dealing 2025
Nov 19
Share Issue/Capital Change 2025
Nov 17
Capital/Financing Update 2025
Nov 17
Director's Dealing 2025
Nov 12
Regulatory Filings 2025
Nov 12
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.